<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01778465</url>
  </required_header>
  <id_info>
    <org_study_id>103330</org_study_id>
    <nct_id>NCT01778465</nct_id>
  </id_info>
  <brief_title>Effect of Dietary Salicylate in Aspirin Exacerbated Respiratory Disease</brief_title>
  <official_title>Effect of Low Dietary Salicylate on Biochemical Markers of Aspirin Exacerbated Respiratory Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lawson Health Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Lawson Health Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aspirin-Exacerbated Respiratory Disease, or AERD, consists of aspirin sensitivity, asthma and&#xD;
      nasal polyps. It is currently managed by chronic steroid use, multiple endoscopic sinus&#xD;
      surgeries and/or aspirin desensitization. However, these treatments have potential adverse&#xD;
      effects.&#xD;
&#xD;
      A theory has been postulated that decreasing the level of dietary salicylates may help in&#xD;
      long-term control of disease. A current trial is in the works to evaluate the clinical&#xD;
      outcomes of decreased salicylate, but measurements of biochemical markers of disease has not&#xD;
      yet been done. The hypothesis is that decreased dietary salicylates will result in a decrease&#xD;
      in urinary salicylates and inflammatory markers of disease, cys-leukotrienes, which are&#xD;
      typically elevated in this disease.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Actual">May 2014</completion_date>
  <primary_completion_date type="Actual">March 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Urinary Levels of Cys-Leukotrienes</measure>
    <time_frame>14 days after commencement</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Urinary Salicyluric Acid Levels</measure>
    <time_frame>14 days after commencement</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Urinary Salicylic Acid Levels</measure>
    <time_frame>14 days after enrollment</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Urinary Creatinine Levels</measure>
    <time_frame>14 days after commencement</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sino-Nasal Outcome Test (SNOT-22)</measure>
    <time_frame>14 days after commencement</time_frame>
    <description>The Sino-Nasal Outcome Test (SNOT-22) is a validated 22-item Chronic rhinosinusitis-specific instrument which is scored using a scale where 0=&quot;No problem&quot;, 1=&quot;Very mild problem&quot;, 2=&quot;Mild or slight problem&quot;, 3=&quot;Moderate problem&quot;, 4=&quot;Severe problem&quot;, and 5=&quot;Problem as bad as it can be&quot;. Higher scores on the SNOT-22 survey items suggest worse patient functioning or symptom severity (total score range: 0-110)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">7</enrollment>
  <condition>Chronic Rhinosinusitis</condition>
  <condition>Aspirin Exacerbated Respiratory Disease</condition>
  <condition>Asthma</condition>
  <condition>Aspirin Sensitivity</condition>
  <arm_group>
    <arm_group_label>Low salicylate diet, then Normal Diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients followed a low salicylate diet for one week, then they followed a Normal diet for another week.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal diet, then Low Salicylate diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients followed a Normal diet for one week, then they followed a Low Salicylate diet for another week.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Low salicylate diet</intervention_name>
    <description>Participants followed a 7 days period under a Low salicylate diet</description>
    <arm_group_label>Low salicylate diet, then Normal Diet</arm_group_label>
    <other_name>Dietary salicylate</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Normal Diet</intervention_name>
    <description>Participants followed a 7 days period under a Normal Diet</description>
    <arm_group_label>Normal diet, then Low Salicylate diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  adult patients&#xD;
&#xD;
          -  Aspirin-exacerbated respiratory disease&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  recent use of Prednisone or other systemic steroids (greater than 3 doses in past 3&#xD;
             months)&#xD;
&#xD;
          -  Endoscopic sinus surgery or polypectomy within the past 6 months&#xD;
&#xD;
          -  Other significant systemic disease, including renal failure, or immunocompromised&#xD;
             state.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Leigh J Sowerby, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lawson HRI</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>St. Joseph's Health Care</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N5A 4V2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>March 2015</verification_date>
  <study_first_submitted>January 26, 2013</study_first_submitted>
  <study_first_submitted_qc>January 26, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 29, 2013</study_first_posted>
  <results_first_submitted>July 15, 2020</results_first_submitted>
  <results_first_submitted_qc>February 17, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">March 9, 2021</results_first_posted>
  <last_update_submitted>February 17, 2021</last_update_submitted>
  <last_update_submitted_qc>February 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Chronic Rhinosinusitis</keyword>
  <keyword>Aspirin exacerbated respiratory disease</keyword>
  <keyword>Asthma</keyword>
  <keyword>Aspirin sensitivity</keyword>
  <keyword>Salicylate</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiration Disorders</mesh_term>
    <mesh_term>Respiratory Tract Diseases</mesh_term>
    <mesh_term>Hypersensitivity</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Salicylic Acid</mesh_term>
    <mesh_term>Salicylates</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Low Salicylate Diet, Then Normal Diet</title>
          <description>Participants followed a low salicylate diet for 7 days, then they started a period of 7 days on Normal diet.</description>
        </group>
        <group group_id="P2">
          <title>Normal Diet, Then Low Salicylate Diet</title>
          <description>Participants followed a normal diet for 7 days, then they started a period of 7 days on Low Salicylate Diet</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>First Intervention (7 Days)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Second Intervention (7 Days)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>All Study Participants</title>
          <description>Participants followed a low salicylate diet for one week. Then, participants continued with a normal diet for one week.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="7"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="55" spread="13.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Urinary Levels of Cys-Leukotrienes</title>
        <time_frame>14 days after commencement</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Low Salicylate Diet</title>
            <description>Patients followed a low salicylate diet for one week</description>
          </group>
          <group group_id="O2">
            <title>Normal Diet</title>
            <description>Patients followed a Normal diet for one week.</description>
          </group>
        </group_list>
        <measure>
          <title>Urinary Levels of Cys-Leukotrienes</title>
          <units>pg/ml</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="7"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="874.05" lower_limit="182.60" upper_limit="1404.01"/>
                    <measurement group_id="O2" value="771.99" lower_limit="651.23" upper_limit="1979.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Urinary Salicyluric Acid Levels</title>
        <time_frame>14 days after commencement</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Low Salicylate Diet</title>
            <description>Patients followed a low salicylate diet for one week</description>
          </group>
          <group group_id="O2">
            <title>Normal Diet</title>
            <description>Participants followed a normal diet for 7 days</description>
          </group>
        </group_list>
        <measure>
          <title>Urinary Salicyluric Acid Levels</title>
          <units>ng/ml</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="7"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44.21" lower_limit="20.23" upper_limit="54.9"/>
                    <measurement group_id="O2" value="23.82" lower_limit="15.7" upper_limit="70.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Urinary Salicylic Acid Levels</title>
        <time_frame>14 days after enrollment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Low Salicylate Diet</title>
            <description>Participants followed a low salicylate diet for 7 days</description>
          </group>
          <group group_id="O2">
            <title>Normal Diet</title>
            <description>Participants followed a normal diet for 7 days</description>
          </group>
        </group_list>
        <measure>
          <title>Urinary Salicylic Acid Levels</title>
          <units>ng/ml</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="7"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.6" lower_limit="0.46" upper_limit="3.88"/>
                    <measurement group_id="O2" value="0.92" lower_limit="0.4" upper_limit="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Urinary Creatinine Levels</title>
        <time_frame>14 days after commencement</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Low Salicylate Diet</title>
            <description>Participants followed a low salicylate diet for 7 days</description>
          </group>
          <group group_id="O2">
            <title>Normal Diet</title>
            <description>Participants followed a normal diet for 7 days</description>
          </group>
        </group_list>
        <measure>
          <title>Urinary Creatinine Levels</title>
          <units>mmol/L</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="7"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.9" lower_limit="3.7" upper_limit="15"/>
                    <measurement group_id="O2" value="15.3" lower_limit="6.2" upper_limit="18.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Sino-Nasal Outcome Test (SNOT-22)</title>
        <description>The Sino-Nasal Outcome Test (SNOT-22) is a validated 22-item Chronic rhinosinusitis-specific instrument which is scored using a scale where 0=&quot;No problem&quot;, 1=&quot;Very mild problem&quot;, 2=&quot;Mild or slight problem&quot;, 3=&quot;Moderate problem&quot;, 4=&quot;Severe problem&quot;, and 5=&quot;Problem as bad as it can be&quot;. Higher scores on the SNOT-22 survey items suggest worse patient functioning or symptom severity (total score range: 0-110)</description>
        <time_frame>14 days after commencement</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Low Salicylate Diet</title>
            <description>Patients followed a low salicylate diet for one week.</description>
          </group>
          <group group_id="O2">
            <title>Normal Diet</title>
            <description>Patients followed a Normal diet for one week.</description>
          </group>
        </group_list>
        <measure>
          <title>Sino-Nasal Outcome Test (SNOT-22)</title>
          <description>The Sino-Nasal Outcome Test (SNOT-22) is a validated 22-item Chronic rhinosinusitis-specific instrument which is scored using a scale where 0=&quot;No problem&quot;, 1=&quot;Very mild problem&quot;, 2=&quot;Mild or slight problem&quot;, 3=&quot;Moderate problem&quot;, 4=&quot;Severe problem&quot;, and 5=&quot;Problem as bad as it can be&quot;. Higher scores on the SNOT-22 survey items suggest worse patient functioning or symptom severity (total score range: 0-110)</description>
          <units>score on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="7"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44" lower_limit="22" upper_limit="53"/>
                    <measurement group_id="O2" value="66" lower_limit="43" upper_limit="83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Low Salicylate Diet</title>
          <description>Participants followed a low salicylate diet for 7 days</description>
        </group>
        <group group_id="E2">
          <title>Normal Diet</title>
          <description>Participants followed a normal diet for 7 days</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Clinical Trials Program Coordinator</name_or_title>
      <organization>Western University</organization>
      <phone>+15196466100 ext 61125</phone>
      <email>taciano.rocha@sjhc.london.on.ca</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

